BioWorld BioWorld MedTech BioWorld Asia BioWorld Science

BioWorld

Akeso hot with FDA cancer win, nods in China, new data
The intriguing VEGFxPD-1 bispecific antibody space gained oomph with phase III results disclosed April 23 by Akeso Pharmaceuticals Inc. related to Harmoni-6, testing...

More in BioWorld

BioWorld MedTech

Mursla Evoliver biopsy blood test granted breakthrough designation
The U.S. FDA granted breakthrough device designation to Mursla Bio Ltd.'s Evoliver. The biopsy blood test uses extracellular vesicles to survey hepatocellular carcinoma in...

More in BioWorld MedTech

BioWorld Science

PIKfyve enzyme is target to ‘starve’ pancreatic cancer cells
A metabolic vulnerability of pancreatic ductal adenocarcinoma (PDAC) could be used to address this type of cancer that often resists treatments. Scientists at the...

More in BioWorld Science

BioWorld Asia

Akeso scores China approval for ebdarokimab in plaque psoriasis
China’s National Medical Products Administration has given the thumbs up to Akeso Pharmaceuticals Inc.’s ebdarokimab for treating moderate to severe plaque psoriasis in...

More in BioWorld Asia

BioWorld Insider Podcast

Robert Williamson, CEO of Triumvira Immunologics, and Hernan Bazan, CEO of South Rampart Pharma, discuss bracing for tariffs, NIH grant cuts and gifting China a biopharma leadership position.